Clinical Trial Update: Discordant HER2/Neu Status of Breast Cancer.

View source ↗

Summary

Clinical trial update noting the completion of a study examining discordant HER2/Neu status in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Cancer Institute, Thailand | Conditions: Malignant Neoplasm of Breast. | Status: COMPLETED